You may also like
Fibrinogen Concentrate Reduces Intraoperative Bleeding when used as First-Line Hemostatic Therapy During Major Aortic Replacement Surgery: Results from a Randomized, Placebo-Controlled Trial
We assessed whether fibrinogen concentrate as targeted first-line hemostatic therapy was more effective than placebo or a standardized transfusion algorithm in controlling coagulopathic bleeding in patients undergoing major aortic surgery.
1 min read
Microcirculatory Effects of Landiolol: A Double-Blind, Randomised, Controlled Study after Cardiac Surgery
The aim of this prospective randomised, controlled, double-blind study conducted in patients undergoing cardiac surgery was to assess the microcirculatory effects of landiolol given at a moderate dose to prevent POAF. We tested the hypothesis that landiolol could limit cardiopulmonary-bypass-induced microcirculatory abnormalities.
1 min read
Options for Temporary Mechanical Circulatory Support
This review will examine the different options for commonly used temporary MCS devices including intra-aortic balloon pumps (IABPs), veno-arterial-extracorporeal membrane oxygenation (VA-ECMO), TandemHeart(®) (CardiacAssist, Pittsburg, PA, USA) Impella(®) and BVS 5000(®) (both Abiomed Inc., Danvers, MA, USA), CentriMag(®) and Thoratec percutaneous ventricular assist device (pVAD)(®) (both Thoratec Corporation, Pleasanton, CA, USA).
1 min read